Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Many men misuse oral contraceptive pills for things like hair growth and muscle gain.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

Insulin might be involved in causing hair loss and acne.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Women with hair loss should be checked for PCOS, as it's often related and early diagnosis can help with treatment.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

New methods for identifying and managing polycystic ovary syndrome in teenagers are improving.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

Some common medications can harm male fertility, but many effects can be reversed.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Ciproterone acetate improves hair regrowth and acne in most female patients.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.